한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

a father shared a medical experience online, telling about his child's visit to the hospital for mycoplasma pneumonia. because domestic generic drugs were not effective enough, he eventually switched to imported original drugs to alleviate the condition. this example highlights the contradiction between the right to choose drugs and the allocation of medical resources.

in recent years, the national health insurance administration has formulated some policies to reduce medical costs, but it also faces some new challenges. for example, the problem of drug selection failure and changes in hospital procurement strategies directly affect whether patients can obtain appropriate treatment drugs.

the national health insurance administration has implemented centralized bulk purchasing (national drug procurement) with the goal of reducing medical costs by improving drug procurement efficiency, but this has also resulted in some drugs being excluded, making it difficult for patients to choose. when faced with medical difficulties, many patients can only choose the drugs they can get, rather than the best options.

in order to meet the medical insurance assessment indicators, hospitals have also chosen a one-step procurement strategy. when purchasing drugs, they will first choose the selected varieties in the centralized procurement, and then consider using the unselected varieties, which has resulted in some patients being unable to obtain better treatment drugs.

this shows that the medical drug supply chain faces challenges and opportunities. on the one hand, drug research and development and production need to continue to develop to ensure the quality and effectiveness of drugs; on the other hand, the allocation of medical resources needs to be more transparent and fair to provide patients with the best choice.

the challenge of “resource allocation”:

there is a challenge of "resource allocation" between hospitals and patients. hospitals need to meet medical insurance assessment indicators, while patients want to get the best treatment options. the conflict between the two leads to changes in drug procurement strategies and also affects the efficiency of medical resource allocation.

• drug development and production: as an important part of society, the pharmaceutical industry needs to continue to develop to ensure the quality and effectiveness of drugs and provide patients with safe and effective treatment options.
• allocation of medical resources：allocation of medical resources is an important issue facing the medical field, and it is necessary to achieve fair and just medical services through policy guidance, medical institution reform, and other means.
• national health insurance administration policy: the national healthcare security administration has formulated some policies aimed at reducing medical costs, but it also faces some new challenges, such as the failure to be selected in centralized drug procurement and changes in hospital procurement strategies.

in the face of these challenges, we need to think about how to better balance resource allocation and patient needs. only through multi-party collaboration, promoting the development of the pharmaceutical industry and improving the allocation of medical resources can patients truly receive the best treatment options.